DDIT3 and diffuse large B-cell lymphoma: For example, according to the gene expression profile, DLBCL is mainly divided into two molecularly distinct subtypes: germinal center cell (GCB)-like and activated B cell (ABC)-like DLBCL, which is a milestone for interpreting why DLBCL patients have different responses to the same R-CHOP therapy [7].